BG103923A - Sulphate salt of hiv protease inhibitor with improved peroral absorption and biopresence - Google Patents
Sulphate salt of hiv protease inhibitor with improved peroral absorption and biopresenceInfo
- Publication number
- BG103923A BG103923A BG103923A BG10392399A BG103923A BG 103923 A BG103923 A BG 103923A BG 103923 A BG103923 A BG 103923A BG 10392399 A BG10392399 A BG 10392399A BG 103923 A BG103923 A BG 103923A
- Authority
- BG
- Bulgaria
- Prior art keywords
- hiv protease
- protease inhibitor
- sulphate salt
- biopresence
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4795097P | 1997-05-29 | 1997-05-29 | |
| GBGB9714320.0A GB9714320D0 (en) | 1997-07-07 | 1997-07-07 | Hiv protease inhibitor |
| PCT/US1998/010633 WO1998054178A1 (en) | 1997-05-29 | 1998-05-26 | Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG103923A true BG103923A (en) | 2000-06-30 |
Family
ID=26311845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG103923A BG103923A (en) | 1997-05-29 | 1999-11-24 | Sulphate salt of hiv protease inhibitor with improved peroral absorption and biopresence |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0986554A1 (pt) |
| JP (1) | JP3267632B2 (pt) |
| KR (1) | KR20010013042A (pt) |
| CN (1) | CN1257497A (pt) |
| AU (1) | AU730245B2 (pt) |
| BG (1) | BG103923A (pt) |
| BR (1) | BR9809498A (pt) |
| CA (1) | CA2291086A1 (pt) |
| EA (1) | EA199901095A1 (pt) |
| EE (1) | EE9900543A (pt) |
| HR (1) | HRP980283A2 (pt) |
| HU (1) | HUP0004621A3 (pt) |
| ID (1) | ID23858A (pt) |
| IL (1) | IL132779A0 (pt) |
| IS (1) | IS5240A (pt) |
| NO (1) | NO995822L (pt) |
| PE (1) | PE75099A1 (pt) |
| PL (1) | PL336847A1 (pt) |
| SK (1) | SK163299A3 (pt) |
| TR (1) | TR199902816T2 (pt) |
| TW (1) | TW438799B (pt) |
| WO (1) | WO1998054178A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003514910A (ja) * | 1999-11-24 | 2003-04-22 | メルク エンド カムパニー インコーポレーテッド | Ｈｉｖプロテアーゼ阻害剤としてのガンマ−ヒドロキシ−２−（フルオロアルキルアミノカルボニル）−１−ピペラジンペンタンアミド類 |
| WO2002022582A2 (en) * | 2000-09-14 | 2002-03-21 | Ortho-Mcneil Pharmaceutical, Inc. | Solid salt forms of n-[2-[4-[2-(1-methylethoxy)phenyl]-1-piperazinyl]ethyl]-2-oxo-1-piperidineacetamide |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ278201A (en) * | 1993-12-15 | 1998-01-26 | Merck & Co Inc | Bicyclic heterocyclically substituted piperazine derivatives as hiv protease inhibitors |
-
1998
- 1998-05-20 TW TW087107834A patent/TW438799B/zh active
- 1998-05-26 TR TR1999/02816T patent/TR199902816T2/xx unknown
- 1998-05-26 ID IDW991462A patent/ID23858A/id unknown
- 1998-05-26 PL PL98336847A patent/PL336847A1/xx unknown
- 1998-05-26 EE EEP199900543A patent/EE9900543A/xx unknown
- 1998-05-26 EP EP98923741A patent/EP0986554A1/en not_active Withdrawn
- 1998-05-26 IL IL13277998A patent/IL132779A0/xx unknown
- 1998-05-26 BR BR9809498-0A patent/BR9809498A/pt not_active Application Discontinuation
- 1998-05-26 KR KR1019997011018A patent/KR20010013042A/ko not_active Application Discontinuation
- 1998-05-26 JP JP50079999A patent/JP3267632B2/ja not_active Expired - Fee Related
- 1998-05-26 WO PCT/US1998/010633 patent/WO1998054178A1/en not_active Application Discontinuation
- 1998-05-26 CN CN98805372A patent/CN1257497A/zh active Pending
- 1998-05-26 HU HU0004621A patent/HUP0004621A3/hu unknown
- 1998-05-26 CA CA002291086A patent/CA2291086A1/en not_active Abandoned
- 1998-05-26 SK SK1632-99A patent/SK163299A3/sk unknown
- 1998-05-26 EA EA199901095A patent/EA199901095A1/ru unknown
- 1998-05-26 AU AU75959/98A patent/AU730245B2/en not_active Ceased
- 1998-05-28 PE PE1998000432A patent/PE75099A1/es not_active Application Discontinuation
- 1998-05-28 HR HR9714320.0A patent/HRP980283A2/hr not_active Application Discontinuation
-
1999
- 1999-11-09 IS IS5240A patent/IS5240A/is unknown
- 1999-11-24 BG BG103923A patent/BG103923A/xx unknown
- 1999-11-26 NO NO995822A patent/NO995822L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998054178A1 (en) | 1998-12-03 |
| KR20010013042A (ko) | 2001-02-26 |
| HRP980283A2 (en) | 1999-08-31 |
| IL132779A0 (en) | 2001-03-19 |
| NO995822D0 (no) | 1999-11-26 |
| HUP0004621A2 (hu) | 2002-03-28 |
| NO995822L (no) | 2000-01-28 |
| SK163299A3 (en) | 2000-07-11 |
| AU7595998A (en) | 1998-12-30 |
| EE9900543A (et) | 2000-06-15 |
| EA199901095A1 (ru) | 2000-08-28 |
| PL336847A1 (en) | 2000-07-17 |
| CN1257497A (zh) | 2000-06-21 |
| TW438799B (en) | 2001-06-07 |
| BR9809498A (pt) | 2000-06-20 |
| ID23858A (id) | 2000-05-25 |
| CA2291086A1 (en) | 1998-12-03 |
| TR199902816T2 (xx) | 2000-02-21 |
| PE75099A1 (es) | 1999-08-11 |
| EP0986554A1 (en) | 2000-03-22 |
| JP2000513747A (ja) | 2000-10-17 |
| HUP0004621A3 (en) | 2002-04-29 |
| IS5240A (is) | 1999-11-09 |
| JP3267632B2 (ja) | 2002-03-18 |
| AU730245B2 (en) | 2001-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DZ3312A1 (fr) | Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation | |
| WO2001019776A3 (de) | Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften | |
| YU70901A (sh) | Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena | |
| DK0661269T3 (da) | Substituerede heterocykliske carboxylsyreamider, deres fremstilling og anvendelse som lægemidler. | |
| HUP0204281A2 (hu) | Eljárás glukagonszerű peptid-1 vegyületek szolubiliázálására | |
| MXPA02003977A (es) | Inhibidores de adhesion de celula mediada por al°2. | |
| CA2341031A1 (en) | Novel salt form of pantoprazole | |
| CA2034569A1 (en) | Oral pharmaceutical forms of pimobendan | |
| YU94103A (sh) | Novi derivati sulfonske kiseline | |
| NO20021875D0 (no) | Fremgangsmåte for stabilisering av benzimidazolforbindelser | |
| EP1306367A4 (en) | SULFONIC ACID DERIVATIVES OF HYDROXAMIC ACIDS AND THEIR USE AS MEDICAL PRODUCTS | |
| BR9915729A (pt) | Amidas Èmega de n-arilsulfonil-aminoácido | |
| ITRM20000340A0 (it) | Uso dell'acido pamoico o di un suo derivato, o di un suo analogo, perla preparazione di un medicamento per il trattamento di patologie cara | |
| MY126117A (en) | Pharmaceutical compositions | |
| PL377478A1 (pl) | Cykloalkenowe kwasy dikarboksylowe jako środki przeciwzapalne, immunomodulujące oraz antyproliferacyjne | |
| DE3855520D1 (de) | Methode zur Verbesserung des Schlafes | |
| DE69104220D1 (de) | Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten. | |
| WO2002064552A8 (en) | 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES | |
| BG103923A (en) | Sulphate salt of hiv protease inhibitor with improved peroral absorption and biopresence | |
| WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
| UY27570A1 (es) | Sal de ácido cítrico de un compuesto terapéutico y composiciones farmacéuticas que la contienen | |
| DE60204014D1 (de) | Chlormethylierung von thiophene | |
| DE60111634D1 (de) | Verfahren zur herstellung von thiazolidinedion-derivaten und zwischenprodukte | |
| WO2002061024A3 (en) | Cleansing composition | |
| WO2002060866A3 (en) | Preparation of pure 3-alkoxymethyl cephalosporins. |